The course will highlight the daily decisions and decision analyses made by internists in recommending procedures for the early detection of prostate cancer. The internists' role in helping the patient make appropriate treatment decisions and counseling the patient to understand the implications of treatment - both risk and benefits - will be emphasized. The internists' role in both recognizing and managing complications of prostate cancer itself and the consequences of prostate cancer treatment will be emphasized.

Internists and primary care physicians are the target audience for the course. The participants will have an opportunity to review and advance their knowledge of current practice patterns and recent advances in prostate cancer treatment. A standardized level of care equivalent to a typical community level hospital in the United States of America will be employed.

NUMBER OF CREDIT HOURS: The Harvard Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

COST: $40.00
click here for pricing outside the United States of America

OVERALL LEARNING OBJECTIVES:

1. Provide a clinical update on diagnosing, treating and managing complications of localized, regionally advanced, and metastatic prostate cancer for the internist.
2. Provide an understanding about screening for prostate cancer.
3. Define the role of the internist in the overall management of prostate cancer.

CLINICAL LEARNING OBJECTIVES:

1. Understand the population(s) at risk for developing prostate cancer.
2. Summarize the treatment choices and decision analyses for various stages of prostate cancer.
3. Review the controversies and policy guidelines regarding screening for prostate cancer.
4. Understand the different mechanism of actions of pharmacologic agents for the systemic management of prostate cancer.
5. Understand the adverse effects and harms of prostate cancer treatment.
6. Recognize the presentation of prostate cancer emergencies.
7. Recognize complementary medicines commonly used by prostate cancer patients.

back to the top

MARC GARNICK, MD Course Director

Dr. Marc B. Garnick is an internationally renowned expert in medical oncology and urologic cancer. He has dedicated his career to the development of new therapeutic programs for the treatment of cancer patients and has maintained a clinical practice at the Beth Israel Deaconess Medical Center. He is Clinical Professor of Medicine and a member of the active teaching faculty at Harvard Medical School. Dr. Garnick received his undergraduate degree from Bowdoin College and his medical degree from the University of Pennsylvania School of Medicine and completed his internal medicine internship and residency at the University's Hospital. He has also completed a research and clinical fellowship in metabolism with the National Institutes of Health (NIH) and a medical oncology fellowship at the Dana Farber Cancer Institute of Harvard Medical School where he also served on the faculty. He is a member of numerous professional organizations, as well as several editorial boards for peer-reviewed publications including Harvard Men’s Health Watch. Dr. Garnick has authored more than 350 peer-reviewed articles and reviews on clinical research, drug development and cancer biology and has authored or edited 6 books. Most recently, he co-authored an article entitled "Combating Prostate Cancer" which appeared in Scientific American, and authored the evidence-based prostate cancer screening policy guidelines for the American College of Physicians as part of their educational resource for primary care physicians and internists. He has written a book entitled A Patient's Guide to Prostate Cancer, now undergoing its third edition. Dr. Garnick currently serves as the Medical Advisor to the World Book Encyclopedia. Dr. Garnick was the academic principal investigator on the development of Lupron, a widely used hormonal therapy for prostate cancer. Most recently, he directed the clinical development of a novel hormonal therapy recently approved by the FD DISCLOSURE: Company: Harvard Medical School-Harvard Health Publications, SEP Type of Relationship: Editor in Chief of Perspectives on Prostate Disease, Consultant Content Area:

CAROLYN LAMB, MD Course Contributor

Dr. Carolyn Lamb is in Instructor in Medicine at Harvard Medical School and a physician specializing in radiation oncology at Mouth Auburn Hospital in Cambridge, MA. She received her medical degree from Northwestern University and completed her internship at New England Deaconess Hospital and her fellowship with the American Cancer Society. She is a member of several professional societies, including the American Society for Therapeutic Radiology and Oncology and the American Medical Women's Association, to which she was the Vice President of the Northwestern University chapter, AMWA. She has also held many committee assignments, including board member for the Hershey Family Foundation, member of Mount Auburn Hospital’s Cancer Management Committee, and chairman for the CT simulator clinical committee. DISCLOSURE: Physician advisor and speakers bureau: Praecis

back to the top

CAROL BATES, MD Reviewer

Carol Bates, M.D. is general internist in the Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center and an Associate Professor of Medicine at Harvard Medical School. She received her medical degree from the Johns Hopkins University School of Medicine. Dr Bates is the Primary Care Program Director at Beth Israel Deaconess Medical Center. During her tenure, more than 100 residents have graduated from the primary care track; most of them remain practicing general internists. Dr Bates has been very active in the Society of General Internal Medicine. She has served as New England Regional President and as co-chair of the annual scientific meeting of the society in 2000. Dr Bates has an active practice focused in particular on women's health. DISCLOSURE:

GRACE HUANG, MD Reviewer

Grace Huang, MD, is the Director of the Office of Educational Technology at the Carl J. Shapiro Institute for Education and Research, a joint venture between HMS and Beth Israel Deaconess Medical Center (BIDMC) in Boston. She also works as a hospitalist at BIDMC. She has spent a number of years designing web-based modules on clinical skills, including computer-based case simulations (“virtual patients”), physical diagnosis tutorials, interactive pathophysiology diagrams, and procedure-based instruction. She serves as a consultant to the Association of American Medical Colleges in their initiative to promote scholarship and sharing of educational materials through MedEdPORTAL. Her clinical research interest is in the impact of a formal hospital-based procedure service on complication rates among internal medicine residents. DISCLOSURE: Dr. Huang's spouse works at Pfizer, Inc., and she holds stock options and shares in the same company.

MARTIN G. SANDA, MD Reviewer

Bio and Photo Coming Soon. DISCLOSURE:

LOWELL E. SCHNIPPER, MD Reviewer

Bio and Photo Coming Soon. DISCLOSURE:

back to the top

NUMBER OF CREDITS: 2 

Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Upon completion of the course you will get a certificate via e-mail within 2 weeks.

Click the image to view a sample of the certificate

back to the top